(Q30361791)

20 June 2017

title

Consultation on dengue vaccines: progress in understanding protection, 26-28 June 2013, Rockville, Maryland. (English)

1 reference

20 June 2017

0 references

2

Scott B Halstead

1 reference

20 June 2017

M Cristina Cassetti

1

1 reference

20 June 2017

language of work or name

English

0 references

publication date

21 April 2014

1 reference

20 June 2017

1 reference

20 June 2017

volume

32

1 reference

20 June 2017

issue

26

1 reference

20 June 2017

page(s)

3115-3121

1 reference

Refining the global spatial limits of dengue virus transmission by evidence-based consensus

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

The global distribution and burden of dengue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Research on dengue during World War II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Identifying protective dengue vaccines: guide to mastering an empirical process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Temporal dynamics of the transcriptional response to dengue virus infection in Nicaraguan children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

The structural basis for serotype-specific neutralization of dengue virus by a human antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

An in-depth analysis of original antigenic sin in dengue virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

The Nicaraguan pediatric dengue cohort study: incidence of inapparent and symptomatic dengue virus infections, 2004-2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Reduced risk of disease during postsecondary dengue virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Spatial and Temporal Clustering of Dengue Virus Transmission in Thai Villages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Fine scale spatiotemporal clustering of dengue virus transmission in children and Aedes aegypti in rural Thai villages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Role of humoral versus cellular responses induced by a protective dengue vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Dengue structure differs at the temperatures of its human and mosquito hosts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

A single dose of the DENV-1 candidate vaccine rDEN1Δ30 is strongly immunogenic and induces resistance to a second dose in a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Dengue human infection model: re-establishing a tool for understanding dengue immunology and advancing vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Sonographic findings of healthy volunteers infected with dengue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.017

10.1016/J.VACCINE.2014.04.017

7 January 2021

Identifiers

DOI

1 reference

20 June 2017

1 reference